Comparing composite scores based on maximal voluntary isometric contraction and on semiquantitative manual motor testing in measuring limb strength in patients with ALS

Neurology

Volumn 47, Issue 6, 1996, Pages 1586-1587

  Armon, C ^a,b   Ponraj, E ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; DISABILITY; DISEASE COURSE; FEMALE; HUMAN; MALE; MOTOR PERFORMANCE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 0029731585     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.6.1586     Document Type: Article

References (10)

1. Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 1986;36:937-941.
2. Andres PL, Finison LJ, Conlon T, Thibodeau LM, Munsat TL. Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis. Neurology 1988;38:405-408.
3. Armon C. Motor neuron disease. In: Gorelick PB, Alter M, eds. Handbook of neuroepidemiology. New York: Marcel Dekker, Inc., 1994:407-456.
4. Norris FH, Calanchini PR, Fallat RJ, Panacharis S, Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974;24:721-728.
5. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987;22:328-330.
6. Smith RA, Melmed S, Sherman B, Fane J, Munsat TL, Festoff BW. Recombinant growth hormone treatment of amyotrophic lateral sclerosis. Muscle Nerve 1993;16:624-633.
7. Mayo Clinic. Clinical examinations in neurology. 5th ed. Philadelphia: W.B. Saunders, 1981:131.
8. Dyck PJ, Sherman WR, Halcher LM, et al. Human diabetic endoneurial sorbitol fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590-596.
9. Miller RG, Petajan J, Bryan WW, et al. A placebo-controlled trial of recombinant human ciliary neurotrophic factor (rhCNTF) in amyotrophic lateral sclerosis. Ann Neurol 1996; 39:256-260.
10. Ross MA, Parry GJ, Miller RG, et al. Evaluation of amyotrophic lateral sclerosis diagnostic criteria (ALSDC) for a controlled trial of recombinant human ciliary neurotrophic factor (rhCNTF) [abstract]. Neurology 1995;45(suppl 4):A280.